Dongwha Pharm.Co.Ltd (000020) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.002x

Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) has a cash flow conversion efficiency ratio of 0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩697.02 Million ≈ $472.36K USD) by net assets (₩409.65 Billion ≈ $277.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 000020 market cap for the company's overall valuation and market capitalisation.

Dongwha Pharm.Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Dongwha Pharm.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dongwha Pharm.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dongwha Pharm.Co.Ltd ranked by their cash flow conversion efficiency. Explore how high is Dongwha Pharm.Co.Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Mahachai Hospital Public Company Limited BK:M-CHAI	0.165x
Europap Tezol Kagit Sanayi Ve Ticaret AS IS:TEZOL	0.105x
Korea Cast Pip KO:000970	0.004x
Meridia Real Estate III Socimi SA MC:YMRE	0.044x
Microbot Medical Inc NASDAQ:MBOT	-0.068x
Zuari Agro Chemicals Limited NSE:ZUARI	0.202x
Dawson Geophysical Company NASDAQ:DWSN	-0.020x
HusCompagniet AS CO:HUSCO	0.072x

Annual Cash Flow Conversion Efficiency for Dongwha Pharm.Co.Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Dongwha Pharm.Co.Ltd from 2011 to 2025. View Dongwha Pharm.Co.Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩401.44 Billion ≈ $272.05 Million	₩15.70 Billion ≈ $10.64 Million	0.039x	+492.38%
2024-12-31	₩401.68 Billion ≈ $272.21 Million	₩-4.00 Billion ≈ $-2.71 Million	-0.010x	-113.91%
2023-12-31	₩407.06 Billion ≈ $275.86 Million	₩29.17 Billion ≈ $19.77 Million	0.072x	-7.15%
2022-12-31	₩378.67 Billion ≈ $256.62 Million	₩29.22 Billion ≈ $19.80 Million	0.077x	-22.87%
2021-12-31	₩360.13 Billion ≈ $244.06 Million	₩36.03 Billion ≈ $24.42 Million	0.100x	-34.35%
2020-12-31	₩342.68 Billion ≈ $232.23 Million	₩52.23 Billion ≈ $35.39 Million	0.152x	+245.17%
2019-12-31	₩300.87 Billion ≈ $203.90 Million	₩13.28 Billion ≈ $9.00 Million	0.044x	+401.18%
2018-12-31	₩297.40 Billion ≈ $201.54 Million	₩-4.36 Billion ≈ $-2.95 Million	-0.015x	+73.65%
2017-12-31	₩296.94 Billion ≈ $201.24 Million	₩-16.52 Billion ≈ $-11.20 Million	-0.056x	-155.22%
2016-12-31	₩252.93 Billion ≈ $171.40 Million	₩25.48 Billion ≈ $17.27 Million	0.101x	+16.90%
2015-12-31	₩230.12 Billion ≈ $155.95 Million	₩19.83 Billion ≈ $13.44 Million	0.086x	+46.50%
2014-12-31	₩229.73 Billion ≈ $155.68 Million	₩13.51 Billion ≈ $9.16 Million	0.059x	+62.92%
2013-12-31	₩227.23 Billion ≈ $153.99 Million	₩8.21 Billion ≈ $5.56 Million	0.036x	-67.51%
2012-12-31	₩226.99 Billion ≈ $153.83 Million	₩25.23 Billion ≈ $17.10 Million	0.111x	-44.82%
2011-12-31	₩229.62 Billion ≈ $155.61 Million	₩46.24 Billion ≈ $31.34 Million	0.201x	--

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$96.74 Million

₩142.75 Billion KRW

Market Cap Rank

#19391 Global

#965 in Korea

Share Price

₩5150.00

Change (1 day)

+0.19%

52-Week Range

₩4550.00 - ₩6670.00

All Time High

₩28554.43